Cite
MLA Citation
Ingeborg Tinhofer et al.. “The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer.” Cancers of the head & neck, vol. 1, no. 1, 2016, pp. 1–11. http://access.bl.uk/ark:/81055/vdc_100080576789.0x000009